Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681601 · ClinicalTrials.gov registry record · NA
Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02681601 is a NA study that was terminated before completion, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 2 participants.
The verdict
NCT02681601, a NA study, was terminated before completion, sponsored by Jonsson Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
There are few well-designed studies evaluating the effect of nutrition support in patients with cancer cachexia. The aim of this study is to examine the effect of dietary prescription with and without nutrition supplementation in patients with unresectable pancreatic cancer on body weight, body composition, total calorie intake, quality of life and blood inflammatory markers.
Interventions
- OTHER Diet Only
- DIETARY_SUPPLEMENT Nutrawell Powder
- DIETARY_SUPPLEMENT OmegaRich fish oil supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-07-19 |
| Est. Completion | 2021-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02681601
The ClinicalTrials.gov registry entry for NCT02681601 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Diet Only is the first listed.
NCT02681601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02681601 about?
NCT02681601 is a clinical study titled "Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer". There are few well-designed studies evaluating the effect of nutrition support in patients with cancer cachexia. The aim of this study is to examine the effect of dietary prescription with and without nutrition supplementation in patients with unresectable pancreatic cancer on body weight, body comp...
What is the current status of trial NCT02681601?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2016-07-19. Estimated completion is 2021-10-01.
What interventions are being tested in trial NCT02681601?
The interventions under investigation include: Diet Only (OTHER), Nutrawell Powder (DIETARY_SUPPLEMENT), OmegaRich fish oil supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02681601?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.